Wealth Enhancement Advisory Services
ARCT icon

Wealth Enhancement Advisory Services’s Arcturus Therapeutics ARCT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$171K Buy
13,315
+33
+0.2% +$345 ﹤0.01% 3802
2026
Q2 		$92.6K Buy
+13,282
New +$105K ﹤0.01% 3816

Other funds holding ARCT

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wealth Enhancement Advisory Services's ARCT Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Arcturus Therapeutics (ARCT) stake by 0.25% in Q3 2026, buying an estimated $345 and bringing the position to 13,315 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Wealth Enhancement Advisory Services first reported a position in ARCT in Q2 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Wealth Enhancement Advisory Services held 13,315 shares of Arcturus Therapeutics worth $171K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 33 Arcturus Therapeutics shares in Q3 2026, an estimated $345.
  • Arcturus Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3802 holding.
  • Wealth Enhancement Advisory Services first reported a position in Arcturus Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.